GEN Protocols
From the publisher of Genetic Engineering & Biotechnology News, a dynamic new hub for editorially curated, freely accessible scientific protocols, protocol preprints, software tools, and technical tips & tricks in biotechnology
From the publisher of Genetic Engineering & Biotechnology News, a dynamic new hub for editorially curated, freely accessible scientific protocols, protocol preprints, software tools, and technical tips & tricks in biotechnology
GEN presents data compiled by Morningstar’s Morningstar Direct asset management platform for StockWatch of the top five performing biotech stocks of 2024, and the five…
Dietary fructose promotes tumor growth in animal models of melanoma, breast cancer, and cervical cancer.
SPARDA and other systems that encode diverse effectors have the potential to offer a novel programmable tool for the field of biotechnology.
Most leading CDMOs are reporting revenue growth, but according to the CEO of one of these companies, near-term challenges include declining drug discovery activity.
As much as the world has changed over the past 45 years, its leading regions for biotech activity worldwide are the same now as they…
By capturing the genotypic and phenotypic heterogeneity of real tissues, organoids faithfully model human diseases and therapeutic responses.
Amid expectations for a rise in M&A activity, market watchers are keeping their eyes on biopharma companies that are ripe for the taking.
Combined market cap falls 2% year over year, with 16 of the largest public companies losing value and just 5 outperforming the S&P 500.
Pfizer has paused enrollment in a Phase III trial assessing its Duchenne muscular dystrophy (DMD) gene therapy candidate fordadistrogene movaparvovec after acknowledging the sudden death…
GEN’s updated A-List of top 10 best-selling prescription drugs, based on 2023 sales, has seven of last year’s 10 top-selling drugs registered year-over-year sales gains,…